Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14558 | 763 | 39.6 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
1241 | 2 | THYROID HORMONE//THYROID HORMONE RECEPTOR//DEIODINASE | 9025 |
14558 | 1 | TETRAC//3 5 DIIODOTHYRONINE//TETRAIODOTHYROACETIC ACID | 763 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TETRAC | authKW | 500229 | 2% | 83% | 15 |
2 | 3 5 DIIODOTHYRONINE | authKW | 285842 | 1% | 71% | 10 |
3 | TETRAIODOTHYROACETIC ACID | authKW | 205809 | 1% | 86% | 6 |
4 | 3 5 DIIODO L THYRONINE | authKW | 128058 | 1% | 80% | 4 |
5 | THYROID HORMONE | authKW | 120114 | 15% | 3% | 115 |
6 | MOL CELLULAR MED PROGRAM | address | 120056 | 0% | 100% | 3 |
7 | TRANSLAT HEMATOONCOL | address | 100042 | 1% | 50% | 5 |
8 | DIIODOTHYRONINE | authKW | 90946 | 1% | 45% | 5 |
9 | L THYROXINE T 4 | authKW | 80037 | 0% | 100% | 2 |
10 | MED BIOCHEM PHYS BIOL | address | 80037 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 5729 | 34% | 0% | 257 |
2 | Cell Biology | 677 | 17% | 0% | 128 |
3 | Oncology | 559 | 16% | 0% | 120 |
4 | Biochemistry & Molecular Biology | 353 | 21% | 0% | 164 |
5 | Physiology | 254 | 7% | 0% | 55 |
6 | Medicine, Research & Experimental | 195 | 7% | 0% | 54 |
7 | Biophysics | 121 | 6% | 0% | 43 |
8 | Biology | 50 | 3% | 0% | 23 |
9 | CYTOLOGY & HISTOLOGY | 18 | 0% | 0% | 2 |
10 | Andrology | 9 | 0% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL CELLULAR MED PROGRAM | 120056 | 0% | 100% | 3 |
2 | TRANSLAT HEMATOONCOL | 100042 | 1% | 50% | 5 |
3 | MED BIOCHEM PHYS BIOL | 80037 | 0% | 100% | 2 |
4 | TAIPEI INT CANC | 80037 | 0% | 100% | 2 |
5 | IRGS IST RIC GENET G SALVATORE | 53357 | 0% | 67% | 2 |
6 | UNITE ENDOCRINOL CELLULAIRE | 53353 | 1% | 33% | 4 |
7 | TAIPEI CANC | 51592 | 1% | 18% | 7 |
8 | SEZ FISIOL IGIENE | 49248 | 1% | 31% | 4 |
9 | DIPARTIMENTO SCI BIOL AMBIENTALI | 47621 | 2% | 7% | 16 |
10 | CHIRURGIA GEN GASTROENTEROL MAMMARIA | 40019 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCRINOLOGY | 3521 | 6% | 0% | 47 |
2 | HORMONES & CANCER | 2495 | 0% | 2% | 3 |
3 | THYROID | 2111 | 2% | 0% | 14 |
4 | JOURNAL OF ENDOCRINOLOGY | 2095 | 3% | 0% | 21 |
5 | ENDOCRINE RESEARCH | 1429 | 1% | 1% | 7 |
6 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1353 | 2% | 0% | 13 |
7 | COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES | 1237 | 1% | 1% | 6 |
8 | TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS | 1156 | 0% | 1% | 2 |
9 | STEROIDS | 1098 | 1% | 0% | 11 |
10 | HORMONE AND METABOLIC RESEARCH | 1050 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TETRAC | 500229 | 2% | 83% | 15 | Search TETRAC | Search TETRAC |
2 | 3 5 DIIODOTHYRONINE | 285842 | 1% | 71% | 10 | Search 3+5+DIIODOTHYRONINE | Search 3+5+DIIODOTHYRONINE |
3 | TETRAIODOTHYROACETIC ACID | 205809 | 1% | 86% | 6 | Search TETRAIODOTHYROACETIC+ACID | Search TETRAIODOTHYROACETIC+ACID |
4 | 3 5 DIIODO L THYRONINE | 128058 | 1% | 80% | 4 | Search 3+5+DIIODO+L+THYRONINE | Search 3+5+DIIODO+L+THYRONINE |
5 | THYROID HORMONE | 120114 | 15% | 3% | 115 | Search THYROID+HORMONE | Search THYROID+HORMONE |
6 | DIIODOTHYRONINE | 90946 | 1% | 45% | 5 | Search DIIODOTHYRONINE | Search DIIODOTHYRONINE |
7 | L THYROXINE T 4 | 80037 | 0% | 100% | 2 | Search L+THYROXINE+T+4 | Search L+THYROXINE+T+4 |
8 | NANOPHARMACEUTICAL TECHNOLOGY | 80037 | 0% | 100% | 2 | Search NANOPHARMACEUTICAL+TECHNOLOGY | Search NANOPHARMACEUTICAL+TECHNOLOGY |
9 | NDAT | 80037 | 0% | 100% | 2 | Search NDAT | Search NDAT |
10 | PHOSPHOCREATINE SYNTHESIS | 80037 | 0% | 100% | 2 | Search PHOSPHOCREATINE+SYNTHESIS | Search PHOSPHOCREATINE+SYNTHESIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DAVIS, PJ , GOGLIA, F , LEONARD, JL , (2016) NONGENOMIC ACTIONS OF THYROID HORMONE.NATURE REVIEWS ENDOCRINOLOGY. VOL. 12. ISSUE 2. P. 111 -121 | 71 | 53% | 15 |
2 | COPPOLA, M , CIOFFI, F , MORENO, M , GOGLIA, F , SILVESTRI, E , (2016) 3,5-DIIODO-L-THYRONINE: A POSSIBLE PHARMACOLOGICAL AGENT?.CURRENT DRUG DELIVERY. VOL. 13. ISSUE 3. P. 330 -338 | 43 | 77% | 0 |
3 | DAVIS, PJ , GLINSKY, GV , LIN, HY , LEITH, JT , HERCBERGES, A , TANG, HY , ASHUR-FABIAN, O , INCERPI, S , MOUSA, SA , (2015) CANCER CELL GENE EXPRESSION MODULATED FROM PLASMA MEMBRANE INTEGRIN ALPHA V BETA 3 BY THYROID HORMONE AND NANOPARTICULATE TETRAC.FRONTIERS IN ENDOCRINOLOGY. VOL. 5. ISSUE . P. - | 49 | 61% | 2 |
4 | CREMASCHI, GA , CAYROL, F , STERLE, HA , FLAQUE, MCD , ARCOS, MLB , (2016) THYROID HORMONES AND THEIR MEMBRANE RECEPTORS AS THERAPEUTIC TARGETS FOR T CELL LYMPHOMAS.PHARMACOLOGICAL RESEARCH. VOL. 109. ISSUE . P. 55 -63 | 51 | 57% | 0 |
5 | LIN, HY , CHIN, YT , YANG, YCSH , LAI, HY , WHANG-PENG, J , LIU, LF , TANG, HY , DAVIS, PJ , (2016) THYROID HORMONE, CANCER, AND APOPTOSIS.COMPREHENSIVE PHYSIOLOGY. VOL. 6. ISSUE 3. P. 1221 -1237 | 57 | 38% | 1 |
6 | HERCBERGS, A , DAVIS, PJ , LIN, HY , MOUSA, SA , (2016) POSSIBLE CONTRIBUTIONS OF THYROID HORMONE REPLACEMENT TO SPECIFIC BEHAVIORS OF CANCER.BIOMEDICINE & PHARMACOTHERAPY. VOL. 84. ISSUE . P. 655 -659 | 35 | 63% | 0 |
7 | EDIRIMANNE, S , ESLICK, GD , HARDEFELDT, PJ , (2012) BENIGN THYROID DISEASE IS ASSOCIATED WITH BREAST CANCER: A META-ANALYSIS.BREAST CANCER RESEARCH AND TREATMENT. VOL. 133. ISSUE 3. P. 1169 -1177 | 28 | 76% | 21 |
8 | DAVIS, PJ , LIN, HY , SUDHA, T , YALCIN, M , TANG, HY , HERCBERGS, A , LEITH, JT , LUIDENS, MK , ASHUR-FABIAN, O , INCERPI, S , ET AL (2014) NANOTETRAC TARGETS INTEGRIN ALPHA V BETA 3 ON TUMOR CELLS TO DISORDER CELL DEFENSE PATHWAYS AND BLOCK ANGIOGENESIS.ONCOTARGETS AND THERAPY. VOL. 7. ISSUE . P. 1619 -1624 | 32 | 64% | 8 |
9 | TOSOVIC, A , BECKER, C , BONDESON, AG , BONDESON, L , ERICSSON, UB , MALM, J , MANJER, J , (2012) PROSPECTIVELY MEASURED THYROID HORMONES AND THYROID PEROXIDASE ANTIBODIES IN RELATION TO BREAST CANCER RISK.INTERNATIONAL JOURNAL OF CANCER. VOL. 131. ISSUE 9. P. 2126 -2133 | 29 | 74% | 12 |
10 | LIN, HY , GLINSKY, GV , MOUSA, SA , DAVIS, PJ , (2015) THYROID HORMONE AND ANTI-APOPTOSIS IN TUMOR CELLS.ONCOTARGET. VOL. 6. ISSUE 17. P. 14735 -14743 | 38 | 54% | 2 |
Classes with closest relation at Level 1 |